Patients with severe symptomatic aortic valve stenosis (AS) at high surgical risk can now be treated with transcatheter aortic valve implantation (TAVI). The mortality of patients on the waiting list for this procedure is not well characterized. We assessed the incidence and predictors of mortality of patients waiting for TAVI in a large single center experience. were included. Baseline clinical, echocardiographic and invasive characteristics were recorded. Waiting time was defined as the time from decision to implant to the time of death or TAVI. Univariate and multivariate predictors of mortality were determined.
